Seward B. Rutkove

Dr. Rutkove is Professor of Neurology, Harvard Medical School and serves as Chief of the Division of Neuromuscular Disease in the Department of Neurology at Beth Israel Deaconess Medical Center. Dr. Rutkove’s research focuses on the application of innovative techniques for the assessment of neuromuscular disease with an emphasis on electrical impedance and ultrasound methodologies in both human subjects and animal disease models. This work has been supported by grants from the National Institutes of Health and multiple foundations, and has resulted more than 180 peer-reviewed publications. He is currently serving as an associate editor for Annals of Neurology. In 2011, he was awarded the Biomarker Challenge Prize from the non-profit foundation Prize4Life, Inc for his work demonstrating that electrical impedance measurements of muscle could speed clinical therapeutic studies in amyotrophic lateral sclerosis. He is also a co-founder of Myolex, Inc, a company focused on the development of electrical impedance devices for the assessment of muscle in health and disease.